Literature DB >> 3081510

Transcription termination and chromatin structure of the active immunoglobulin kappa gene locus.

M Xu, M B Barnard, S M Rose, P N Cockerill, S Y Huang, W T Garrard.   

Abstract

To investigate the chromatin surrounding an active gene, we have determined the distribution of RNA polymerase molecules, the intactness of nucleosomal structure, and the subnuclear compartmentalization along 15 kilobase pairs (kb) of the mouse kappa immunoglobulin locus of MPC-11 plasmacytoma cells. Hybridization of in vitro nuclear transcripts to probes specific for the template strand reveals that transcription terminates within the region between 1.1 and 2.3 kb downstream from the poly(A) addition site. Ten different short sequences (8-13 base pairs) reside within 460 base pairs of this termination region that exhibit homology with sequences found in the termination regions of mouse beta-globin and chicken ovalbumin genes. Transcription of the nontemplate strand occurs on either side of this termination region. We find that both within the transcription unit and 6.5 kb downstream of the termination region of the kappa gene, the canonical nucleosomal structure is perturbed, the chromatin exhibits pronounced insolubility, and the nucleosomes liberated by micrococcal nuclease appear to lack histone H1. The insolubility is characterized by interactions that are disrupted by 0.3 to 0.6 M NaCl treatment. We conclude that the active chromatin phenotype spreads a considerable distance along the kappa locus, well beyond the region of transcription termination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081510

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin.

Authors:  M S Lechner; I Levitan; G R Dressler
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

2.  Mechanism of poly(A) signal transduction to RNA polymerase II in vitro.

Authors:  D P Tran; S J Kim; N J Park; T M Jew; H G Martinson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.

Authors:  Xiaorong Zhou; Yougui Xiang; William T Garrard
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

4.  Nucleosomal organization of a BPV minichromosome containing a human H4 histone gene.

Authors:  M L Moreno; G S Stein; J L Stein
Journal:  Mol Cell Biochem       Date:  1987-04       Impact factor: 3.396

5.  The active immunoglobulin kappa chain gene is packaged by non-ubiquitin-conjugated nucleosomes.

Authors:  S Y Huang; M B Barnard; M Xu; S Matsui; S M Rose; W T Garrard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Chicken histone genes retain nuclear matrix association throughout the cell cycle.

Authors:  S Dalton; H B Younghusband; J R Wells
Journal:  Nucleic Acids Res       Date:  1986-08-26       Impact factor: 16.971

7.  Transcription termination at the chicken beta H-globin gene.

Authors:  T M Pribyl; H G Martinson
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

8.  The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation.

Authors:  Yougui Xiang; William T Garrard
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling.

Authors:  Andrew G Bert; Brett V Johnson; Euan W Baxter; Peter N Cockerill
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

10.  Divergent roles of RelA and c-Rel in establishing chromosomal loops upon activation of the Igkappa gene.

Authors:  Zhe Liu; Zhenyi Ma; Lance S Terada; William T Garrard
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.